THOMASWY
Investo's verdict, shared with you
No fair value published
The derivation ran and was refused by our own plausibility checks. We publish no number rather than a plausible-looking one.
Why · 2 checks
Our valuation methods disagree
The earnings-based and book-based readings of this company differ by more than 2.5×. That spread is real information, but averaging it would manufacture a number no method actually produced.
A per-share input was repaired or refused
One of the per-share figures behind this valuation did not agree with the audited totals it should reconcile to, so it was recomputed from those totals or rejected outright.
What we would need
- Earnings and book value drawn from the same set of accounts, so the two legs can be reconciled.
- A per-share figure in the source data that reconciles to the reported totals.
Show what the engine computed
Method spread · 3.82× between the highest and lowest valuation leg.
Methods disagree · The valuation legs disagree by 3.82x (Blended P/E band ₦0.77 vs Blended P/B band ₦2.94). No point estimate is defensible until the inputs are reconciled.
Figure corrected · BVPS FY2027: bvps_scale_disagreement(rep=140 der=1.40)
Input quality · BVPS FY2027: bvps_scale_disagreement(rep=140 der=1.40)
Thomas Wyatt Nigeria Plc trades at ₦3.00, implying a P/E of approximately 48.8x on Q1-2026 derived EPS of ₦0.06 and 2.15x book value — both multiples are materially elevated relative to the blended fair value of ₦1.42 (bear ₦1.20, bull ₦1.78), suggesting ~53% downside to intrinsic value with no earnings, momentum, or quality offset to justify the premium. The committee score returns a net score of -3 ('weak') with negative readings on value, momentum, and risk, and the sole period of clean annual data (FY2026) discloses an ROE of just 4.4%, well below the cost of equity in a high-rate Nigerian macro environment. With revenue unreported for Q1-2026, a scanned/unextracted Q1-2027 filing, and material input-quality conflicts, the fundamental case for ownership at current levels is not established.
Verdict published 2026-08-18 · fundamentals through Q1-2026 · reviewed as the data changes
Verdict moderated to Watch — Avoid was refused
The valuation legs disagree by 3.82x, so there is no defensible valuation behind an extreme call.
Source: NGX live market data · Investo intelligence. Educational only — not financial advice.